Beximco Pharmaceuticals Ltd. Logo

Beximco Pharmaceuticals Ltd.

Manufacturer of generic drugs, APIs, and specialized products for global markets.

BXP | IL

Overview

Corporate Details

ISIN(s):
US0885792061
LEI:
213800IMBBD6TIOQGB56
Country:
Bangladesh
Address:
N/A

Description

Beximco Pharmaceuticals Ltd. is a manufacturer of generic drugs and active pharmaceutical ingredients (APIs). The company produces a broad portfolio of over 500 products across various therapeutic categories, with a focus on providing access to affordable medicines. It has established a strong market differentiation through a range of high-tech, specialized products, including metered-dose and dry powder inhalers. Serving numerous emerging and developed markets globally, its manufacturing facilities are accredited by major international regulatory authorities, including those of the USA, European Union, Australia, and Canada.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-19 12:10
Delay in Results & Temporary Suspension
English HTML 12.3 KB
2025-11-13 17:10
Request of Extension to Publish Q1 Results
English HTML 11.2 KB
2025-11-04 08:25
Change of Name to Beximco Pharmaceuticals PLC.
English HTML 10.8 KB
2025-10-27 16:53
Request of Extension to Publish Financial Results
English HTML 11.3 KB
2025-10-24 08:00
Affordable treatment option for cystic fibrosis
English HTML 31.5 KB
2025-09-15 14:17
Further update on BSEC Order
English HTML 10.6 KB
2025-05-21 16:18
Update on BSEC Order
English HTML 10.3 KB
2025-04-28 08:00
Request of Extension to Publish Q3 Results
English HTML 10.7 KB
2025-03-21 16:51
Response to media reports and update on BSEC order
English HTML 22.1 KB
2025-03-06 08:00
Update on BSEC order
English HTML 14.3 KB
2025-01-30 15:59
Payment of Cash Dividend
English HTML 8.7 KB
2025-01-29 08:01
Board Changes
English HTML 14.4 KB
2025-01-29 08:00
Half Year Results 2024-25
English HTML 14.2 KB
2025-01-14 12:24
Board of Directors
English HTML 13.7 KB
2024-12-30 08:00
Annual General Meeting Statement
English HTML 12.0 KB

Automate Your Workflow. Get a real-time feed of all Beximco Pharmaceuticals Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Beximco Pharmaceuticals Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Beximco Pharmaceuticals Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.